Miquel Sedo M, Zhang S, Pilarsky C (2021)
Publication Language: English
Publication Type: Journal article, Review article
Publication year: 2021
Book Volume: 9
Article Number: 748631
DOI: 10.3389/fcell.2021.748631
Pancreatic ductal adenocarcinoma (PDAC) is a hostile solid malignancy coupled with an extremely high mortality rate. Metastatic disease is already found in most patients at the time of diagnosis, resulting in a 5-year survival rate below 5%. Improved comprehension of the mechanisms leading to metastasis is pivotal for the development of new targeted therapies. A key field to be improved are modeling strategies applied in assessing cancer progression, since traditional platforms fail in recapitulating the complexity of PDAC. Consequently, there is a compelling demand for new preclinical models that mirror tumor progression incorporating the pressure of the immune system, tumor microenvironment, as well as molecular aspects of PDAC. We suggest the incorporation of 3D organoids derived from genetically engineered mouse models or patients as promising new tools capable to transform PDAC pre-clinical modeling and access new frontiers in personalized medicine.
APA:
Miquel Sedo, M., Zhang, S., & Pilarsky, C. (2021). Pre-clinical Models of Metastasis in Pancreatic Cancer. Frontiers in Cell and Developmental Biology, 9. https://doi.org/10.3389/fcell.2021.748631
MLA:
Miquel Sedo, Maria, Shuman Zhang, and Christian Pilarsky. "Pre-clinical Models of Metastasis in Pancreatic Cancer." Frontiers in Cell and Developmental Biology 9 (2021).
BibTeX: Download